0001209191-19-023404.txt : 20190403
0001209191-19-023404.hdr.sgml : 20190403
20190403180014
ACCESSION NUMBER: 0001209191-19-023404
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAHAM GINGER L
CENTRAL INDEX KEY: 0001192601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 19730397
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS, INC.
STREET 2: 885 ARAPAHOE AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-01
0
0001131324
GENOMIC HEALTH INC
GHDX
0001192601
GRAHAM GINGER L
1108 NORTH LEMAY AVENUE
FORT COLLINS
CO
80524
1
0
0
0
Common Stock
2019-04-01
4
A
0
149
66.84
A
51952
I
Held by the GInger L. Graham Revocable Trust
Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested.
/s/ Jason W. Radford, Attorney-in-fact
2019-04-03